Revolution Medicines Inc (RVMD): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 248,774 US Dollar | 8 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 214.336.418 | 4,79 | 5,49 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Revolution Medicines Inc
Mitarbeiter 883
Handelsplatz NASDAQ
Ticker Symbol RVMD
IPO Datum 2020-02-13
Adresse 700 Saginaw Drive, Redwood City, CA, United States, 94063
Webseite https://www.revmed.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Mark A. Goldsmith M.D., Ph.D. | CEO, President & Chairman |
| 2 | Mr. Jack Anders | Chief Financial Officer |
| 3 | Ms. Margaret A. Horn J.D. | Chief Operating Officer |
| 4 | Mr. Jeffrey Cislini J.D. | Senior VP, General Counsel & Corporate Secretary |
| 5 | Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. | Senior Advisor |
| 6 | Dr. Martin D. Burke M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| 7 | Dr. Michael A. Fischbach Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
| 8 | Dr. Kevan M. Shokat Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
| 9 | Mr. Walter Reiher Ph.D. | Chief Information Officer |
| 10 | Ms. Jan Smith Ph.D. | Chief Scientific Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Farallon Capital Management, L.L.C. | 6,35% | 2,85 Mrd. USD |
| 2 | BlackRock Inc | 5,23% | 2,35 Mrd. USD |
| 3 | Darwin Global Management, Ltd. | 4,96% | 2,22 Mrd. USD |
| 4 | HHG PLC | 4,56% | 2,04 Mrd. USD |
| 5 | Baker Bros Advisors LP | 4,46% | 2,00 Mrd. USD |
| 6 | FMR Inc | 3,95% | 1,77 Mrd. USD |
| 7 | Vanguard Capital Management, LLC | 3,90% | 1,75 Mrd. USD |
| 8 | Nextech Invest, Ltd. | 3,55% | 1,59 Mrd. USD |
| 9 | Vanguard Portfolio Management, LLC | 3,50% | 1,57 Mrd. USD |
| 10 | Paradigm Biocapital Advisors LP | 2,97% | 1,33 Mrd. USD |
| 11 | State Street Corp | 2,05% | 0,92 Mrd. USD |
| 12 | UBS Group AG | 2,05% | 0,92 Mrd. USD |
| 13 | Capital World Investors | 1,87% | 0,84 Mrd. USD |
| 14 | Wellington Management Company LLP | 1,79% | 0,80 Mrd. USD |
| 15 | Geode Capital Management, LLC | 1,56% | 0,70 Mrd. USD |
| 16 | T. Rowe Price Associates, Inc. | 1,51% | 0,68 Mrd. USD |
| 17 | Alphabet Inc | 1,37% | 0,62 Mrd. USD |
| 18 | Bvf Inc | 1,33% | 0,60 Mrd. USD |
| 19 | Casdin Capital, LLC | 1,20% | 0,54 Mrd. USD |
| 20 | Woodline Partners LP | 1,17% | 0,52 Mrd. USD |